Incidence of Cancer after Prophylaxis with Warfarin against Recurrent Venous Thromboembolism

Abstract

The risk of newly diagnosed cancer after a first episode of venous thromboembolism is elevated during at least the following two years. Subsequently, the risk seems to be lower among patients treated with oral anticoagulants for six months than among those treated for six weeks.